Protocols
Prodermic 470 is a tri-acid system uniquely formulated for patients with both acne and rosacea, combining anti-inflammatory, antimicrobial, and exfoliating action in a single protocol.The AZL-3R Complex uses Azelaic Acid (20%) as the primary anti-inflammatory and antimicrobial agent with proven efficacy against papulopustular rosacea, Salicylic Acid (15%) for deep pore penetration and pore-clearing, and Glycolic Acid (15%) for surface-level exfoliation and congestion clearing. Total active load: 50% across 3 agents.The only system in the Prodermic range that treats acne and rosacea simultaneously. ~24 sessions per 30ml jar.
AZL-3R Complex — An azelaic acid-led tri-acid system for dual-diagnosis acne-rosacea with anti-inflammatory, oil-regulating, and exfoliating action.Azelaic Acid (20%) provides broad-spectrum antimicrobial activity against acne bacteria while simultaneously calming the inflammation that drives rosacea redness and bumps. Salicylic Acid (15%) penetrates deep into oil-rich pores for pore-clearing and anti-inflammatory action. Glycolic Acid (15%) speeds up surface exfoliation to clear pore plugs and improve overall skin texture.A unique system that addresses both conditions in a single treatment.
Recommended sequence for prodermic 470. Frequency: As prescribed by professional.
Dual-diagnosis acne + rosacea patients, papulopustular rosacea, acne patients with significant erythema component
If desired results are not achieved, it does not indicate the peel is ineffective—it may simply mean that the skin has a higher tolerance to the current formulation. In such cases, consider transitioning to a stronger peel, applying multiple coats, or increasing the application time in subsequent sessions.
